Dr. med. Sylke Schneider-Burrus

Chefärztin im Zentrum für Dermatochirurgie

Dr. med. Sylke Schneider-Burrus wurde in Hückeswagen, Nordrhein-Westfalen geboren, ist verheiratet und hat zwei Kinder.

Werdegang

1992 – 1999
Studium der Medizin an der Universität zu Köln

05/1999
Abschluss des Studiums der Medizin mit dem dritten Staatsexamen
Gesamtnote: sehr gut

10/2000
Promotion im Fach Medizin an der Universität zu Köln
Note: Magna cum laude

Institut für Mikrobiologie, Immunologie und Hygiene der Universität zu Köln
Institutsdirektor: Professor Dr. M. Krönke

Titel der Dissertationsarbeit:
Epidemiologische Untersuchung zur Ausbreitung von Bakterienstämmen auf einer Schwerstverbrannten-Intensivstation

07/1999 – 08/2001
Ärztin im Praktikum und im Anschluss Assistenzärztin an der Klinik und Poliklinik für Visceral- und Gefäßchirurgie der Universität zu Köln

Klinikdirektor: Professor Dr. A.H. Hölscher.

09/2001-09/2003
Postdoctoral research fellow im Norris Cancer Center, University of Southern California, bei Professor Dr. Peter Danenberg

10/2003 – 11/2008
Facharztausbildung an der Klinik für Dermatologie, Venerologie und Allergologie, Charité Universitätsmedizin

Klinikdirektor: Professor Dr. W. Sterry

11/2008
Anerkennung als Fachärztin für Dermatologie und Venerologie, Ärztekammer Berlin

01/2009  
Ernennung zur Oberärztin in der Klinik für Dermatologie, Venerologie und Allergologie, Charité Universitätsmedizin

08/2013     
Anerkennung der Zusatzbezeichnung Phlebologie, Ärztekammer Berlin

01/2009 – 12/2016
Leitung des klinischen Forschungsbereichs Acne inversa
Charité Universitätsmedizin

07/2012 – 12/2016
Leitung Dermatochirurgie in der Klinik für Dermatologie, Venerologie und Allergologie, Charité Universitätsmedizin

Seit 01/2017 
Chefärztin im Zentrum für Dermatochirurgie, Havelklinik Berlin
Hygienebeauftragte Ärztin

Publikationen

Manuskripte

 

Cramer P, Schneider-Burrus S, Kovács M, Scholl L, Podda M, Bechara FG. Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update. Hautarzt. 2021 Aug;72(8):692-699.

 

Schneider-Burrus S, Tsaousi A, Barbus S, Huss-Marp J, Witte K, Wolk K, Fritz B, Sabat R.Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. S Front Med (Lausanne). 2021 Apr 27;8:676241.

 

Schneider-Burrus S, Lux G, van der Linde K, Barbus S, Huss-Marp J, Tsaousi A, Wasem J, Wolff B, Sabat R. Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e32-e35. doi: 10.1111/jdv.16783. Epub 2020 Jul 20.

Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, Sabat R. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.

Witte-Händel E, Wolk K, Tsaousi A, Irmer ML, Mößner R, Shomroni O, Lingner T, Witte K, Kunkel D, Salinas G, Jodl S, Schmidt N, Sterry W, Volk HD, Giamarellos-Bourboulis EJ, Pokrywka A, Döcke WD, Schneider-Burrus S, Sabat R. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction. J Invest Dermatol. 2019 Jun;139(6):1294-1305.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018. S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

van Straalen KR, Schneider-Burrus S, Prens EP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol. 2020 Dec;183(6):e178-e187. doi: 10.1111/bjd.16768. Epub 2018 Jul 7.

Schneider-Burrus S, Jost A, Peters EM, Witte-Haendel E, Sterry W, Sabat R. Association of Hidradenitis Suppurativa With Body Image. JAMA Dermatology. doi:10.1001/jamadermatol.2017.6058 Published online February 21, 2018

Schneider-Burrus S, Arpa E, Kors C, Stavermann T, Sabat R, Kokolakis G.  Drug therapy of acne inversa. Hautarzt. 2018 Jan;69(1):58-63. doi: 10.1007/s00105-017-4094-1. Review. German.

Leistner R, Kola A, Gastmeier P, Krüger R, Hoppe PA, Schneider-Burrus S, Zuschneid I, Wischnewski N, Bender J, Layer F, Niebank M, Scheibenbogen C, Hanitsch LG. Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain. PLoS One. 2017 Dec 19;12(12):e0189961. doi: 10.1371/journal.pone.0189961. eCollection 2017.

Saeed K, Gould I, Espositio S, Ahmad-Saeed N, Ahmed SS, Alp E, Bal AM, Bassetti M, Bonnet E, Chan M, Coombs G, Dancer SJ, David MZ, De Simone G, Dryden M, Guardabassi L, Hanitsch LG, Hijazi K, Krüger R, Lee A, Leistner R, Pagliano P, Righi E, Schneider-Burrus S, Skov RL, Tattevin P, Van Wamel W, Vos MC, Voss A. Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy. International Society of Chemotherapy. Int J Antimicrob Agents. 2018 Jan;51(1):16-25. doi: 10.1016/j.ijantimicag.2017.11.002. Epub 2017 Nov 22.

Sabat R, Tsaousi A, Rossbacher J, Kurzen H, Fadai T, Schwichtenberg U, Schneider-Burrus S, Kokolakis G, Wolk K. Acne inversa/hidradenitis suppurativa: An update. Hautarzt. 2017 Dec;68(12):999-1006. doi: 10.1007/s00105-017-4082-5. Review. German.

Krüger R, Hanitsch LG, Leistner R, Schneider-Burrus S, Hoppe PA, Steinberg S, Hauck F, von Bernuth H.Scabies, Periorbital Cellulitis and Recurrent Skin Abscesses due to Panton-Valentine Leukocidin-Positive Staphylococcus aureus Mimic Hyper IgE Syndrome in an Infant. Pediatr Infect Dis J. 2017 Dec;36(12):e347-e348.

Zouboulis CC1, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa, J Eur Acad Dermatol Venereol. 2015 Jan 30. doi: 10.1111/jdv.12966. [Epub ahead of print]

Sylke Schneider-Burrus, Eva MJ Peters, Robert Sabat, Wolfram Sterry, Agata Kurek. Severe alterations of body image in patients with acne inversa. Submitted for publication in JDDG, 2016. (IF 2,5)

Kurek A, Peters E, Sabat R, Sterry W, Schneider-Burrus S. Depression is a frequent co-morbidity in patients with acne inversa. J Dtsch Dermatol Ges 2013 Aug;11(8):743-9. (IF 1,403)

Sabat R, Chanwangpong A, Schneider-Burrus S, Metternich D, Kokolakis G, Kurek A, Philipp S, Uribe D, Wolk K, Sterry W. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7(2):e31810. Epub 2012 Feb 16. (IF 4,092)

Kurek A, Chanwangpong A, Sabat R, Peters E, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with Acne inversa. J Am Acad Dermatol. 2012 Sep;67(3):422-8 (IF 3,991)

Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K, Kunz S, Buss A, Roewert HJ, Krause M, Lukowsky A, Volk HD, Sterry W, Sabat R. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol. 2011 Jan 15;186(2):1228-39. (IF 5,788)

Lukowsky A, Sterry W, Schneider-Burrus S. Prevalence of the MspI and Ile462Val SNPs of cytochrome P-450 1A1 in hidradenitis suppurativa. Exp Dermatol. 2010 Jun;19(6):541-2. (IF 4,159)

Schneider-Burrus S, Drecoll U, Schlag PM. Operative Therapie des malignen Melanoms. Der Onkologe, 2009, Volume 15, Number 8, 750-757. (IF 0,157)

 

Kuramochi H, Uchida K, Peters JH, Shimizu D, Vallbohmer D, Schneider S, Danenberg KD, Danenberg PV. Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences. BMC Cancer. 2009 May 21;9:157. (IF 2,736)

Schneider-Burrus S, Meixner D, Sterry W, Luckowsky A. Common NOD2 mutations are rare in patients with inverse acne. J Dermatol Sci. 2008 Oct;52(1):55-7. (IF 2,973)

Meixner D, Schneider S, Krause M, Sterry W. Acne inversa. A review. J Dtsch Dermatol Ges. 2008 Mar;6(3):189-96.

Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD, Lenz HJ. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Clin Colorectal Cancer. 2006 Nov;6(4):305-11.

Maza S, Taupitz M, Taymoorian K, Winzer KJ, Ruckert J, Paschen C, Raber G, Schneider S, Trefzer U, Munz DL. Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entities. Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):378-83. (IF 4,101)

Schneider S, Park D, Yang D, El-Khoueiry A, Sherrod A, Groshen S, Streeter O, Iqbal S, Danenberg K, and Lenz HJ. Gene association in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharmacogenet Genomics. 2006 Aug;16(8):555-63. (IF 5,391)

Schneider S, Garcia Bartels C, Maza S, and Sterry W. Detection of Micrometastasis in a Sentinel Lymph Node of a Patient with Malignant Blue Nevus: A Case Report. Dermatol Surg. 2006 Aug;32(8):1089-92. (IF 2,309)

Dang C, Gottschling M, Manning K, O´Currain E, Schneider S, Sterry W, Stockfleth E and Nindl I. Identification of dysregulated genes in cutaneous squamous cell carcinoma, Oncol Rep, 2006 Sep;16(3):513-9. (IF 1,567)

Shimizu D, Vallbohmer D, Kuramochi H, Uchida K, Schneider S, Chandrasoma PT, Shimada H, Demeester TR, Danenberg KD, Peters JH, Demeester SR, Danenberg PV. Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2. Int J Cancer. 2006 Aug 15;119(4):765-70. (IF 4,693)

Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krossin T, Zander A, Audring H, Sterry W, Munz DL. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):433-40. (IF 4,041)

Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ. Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. Pharmacogenomics. 2006 Jan;7(1):67-88.  (IF 3,603)

Uchida K, Schneider S, Yochim JM, Kuramochi H, Hayashi K, Takasaki K, Yang D, Danenberg KD, Danenberg PV. Related Articles, Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy. Clin Cancer Res. 2005 May 1;11(9):3363-8. (IF 5,715)

Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV. Related Articles, Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. J Am Coll Surg. 2005 Mar;200(3):336-44. (IF 2,621)

Kuramochi H, Vallbohmer D, Uchida K, Schneider S, Hamoui N, Shimizu D, Chandrasoma PT, DeMeester TR, Danenberg KD, Danenberg PV, Peters JH. Related Articles, Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. J Gastrointest Surg. 2004 Dec;8(8):1007-16.

Hamoui N, Peters JH, Schneider S, Uchida K, Yang D, Vallbohmer D, Hagen JA, DeMeester SR, DeMeester TR, Danenberg K, Danenberg P. Related Articles,  Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg. 2004 Jul;139(7):712-6. (IF 3,076)

Lu B, Mu Y, Cao C, Zeng F, Schneider S, Tan J, Price J, Chen J, Freeman M, Hallahan DE. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004 Apr 15;64(8):2840-5.  (IF 7,69)

Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM, Schneider S, Holscher AH, Yin J, Meltzer SJ, Danenberg KD, Danenberg PV, Lord RV. Related Articles, A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene. 2004 Jun 10;23(27):4780-8. (IF 6,318)

Schneider S, Yochim J, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Holscher AH, Danenberg PV. Related Articles, Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer. Clin Cancer Res. 2004 Mar 1;10(5):1588-96. (IF 5,623)

Uchida K, Hayashi K, Kawakami K, Schneider S, Yochim JM, Kuramochi H, Takasaki K, Danenberg KD, Danenberg PV. Related Articles, Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin Cancer Res. 2004 Jan 15;10(2):433- (IF 5,623)

Schneider S, Uchida K, Salonga D, Yochim JM, Danenberg KD, Danenberg PV. Quantitative determination of p16 gene expression by RT-PCR. Methods Mol Biol. 2004;281:91-103. 

Schneider S, Stöhlmacher J and Lenz H-J, Pharmakogenetik in kolorektalen Karzinomen, Der Onkologe 2003, Aug, Volume 9, Number 8

Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Holscher AH, Danenberg KD, Danenberg PV. Related Articles, Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res. 2003 Jan;9(1):223-7.

Mitgliedschaften

Deutsche Dermatologische Gesellschaft (DDG)

Deutsche Gesellschaft für Dermatochirurgie (DGDC)

Berliner Dermatologische Gesellschaft (BDG)

European Hidradenitis Suppurativa Foundation (EHSF)

Berlin Brandenburger Entzündungsnetzwerk (BEN-NET)

Hautnetz Berlin-Brandenburg